(CNXT) VanEck ChiNext - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US92189F6271 • China Region
CNXT: Chinese, Technology, Internet, Financial, Consumer, Healthcare
The VanEck ChiNext ETF (NYSE ARCA:CNXT) is designed to provide exposure to the 100 largest and most liquid companies listed on the ChiNext Market of the Shenzhen Stock Exchange. The fund typically allocates at least 80% of its total assets to securities that replicate the performance of its underlying index. The index is a free-float adjusted market-capitalization weighted index, composed exclusively of China A-shares, which are renminbi-denominated shares traded on mainland Chinese exchanges. This structure allows the ETF to track the growth and innovation of emerging companies in China, particularly in the technology and consumer sectors. The ChiNext Market is often referred to as Chinas NASDAQ due to its focus on high-growth, technology-driven firms.
For more information, visit http://www.vaneck.com.
Based on the provided technical and fundamental data, the ETFs short-term outlook appears neutral to slightly bullish. The 20-day average volume of 20,979 shares indicates moderate liquidity, while the last price of $29.33 is trading slightly above its 20-day SMA of $28.79, suggesting recent upward momentum. The 50-day SMA of $27.80 and 200-day SMA of $25.57 indicate a longer-term upward trend. The ATR of 0.54 reflects relatively low volatility, suggesting stability in price movements. With an AUM of $34.03 million, the fund is relatively small but maintains a focused exposure to the ChiNext Market. Over the next three months, if the 20-day SMA continues to rise above the 50-day SMA, the ETF could test resistance levels near $31.50. Conversely, a breakdown below the 50-day SMA could signal a pullback to $26.50. Fundamental tailwinds from Chinas technology sector growth could support further gains, but investors should monitor broader market conditions in China for potential risks.
Additional Sources for CNXT ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CNXT ETF Overview
Market Cap in USD | 28m |
Category | China Region |
TER | 0.65% |
IPO / Inception | 2014-07-23 |
CNXT ETF Ratings
Growth Rating | -15.9 |
Fundamental | - |
Dividend Rating | 29.0 |
Rel. Strength | 4.08 |
Analysts | - |
Fair Price Momentum | 23.29 USD |
Fair Price DCF | - |
CNXT Dividends
Dividend Yield 12m | 0.16% |
Yield on Cost 5y | 0.14% |
Annual Growth 5y | 58.49% |
Payout Consistency | 23.6% |
CNXT Growth Ratios
Growth Correlation 3m | -42.7% |
Growth Correlation 12m | 54.6% |
Growth Correlation 5y | -75.9% |
CAGR 5y | -1.76% |
CAGR/Max DD 5y | -0.03 |
Sharpe Ratio 12m | -0.73 |
Alpha | 6.87 |
Beta | 0.550 |
Volatility | 29.23% |
Current Volume | 6.9k |
Average Volume 20d | 16.1k |
As of April 25, 2025, the stock is trading at USD 25.47 with a total of 6,941 shares traded.
Over the past week, the price has changed by +3.54%, over one month by -9.07%, over three months by -8.71% and over the past year by +14.01%.
Neither. Based on ValueRay Analyses, VanEck ChiNext is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -15.87 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNXT as of April 2025 is 23.29. This means that CNXT is currently overvalued and has a potential downside of -8.56%.
VanEck ChiNext has no consensus analysts rating.
According to ValueRays Forecast Model, CNXT VanEck ChiNext will be worth about 25.7 in April 2026. The stock is currently trading at 25.47. This means that the stock has a potential upside of +0.71%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.7 | 0.7% |